Developer docs
API playgroundTry for free, no card

Search company profiles

Barcelona Institute for Global Health

Full company profile

uuid000828z

Namestring
Barcelona Institute for Global Health
Legal namestring
Fundación Privada Instituto de Salud Global Barcelona (ISGlobal)
Websiteurl
isglobal.org
Company typeenum
Private
Founded yearint
2018
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
501–1,000
akta.pro rankint
HeadquartersBarcelona, Spain
HQ citystring
Barcelona
HQ countrystring
Spain
HQ regionstring
Europe
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
global health research, epidemiological studies, public health policy, infectious disease research, environmental health science
Industry3 codes
1Global Health Research, Evidence & Technical Assistance Organizations
CodeHLAJAKANPrimaryYes
2Global Health Institutes & Programs
CodeEDAHAGAMPrimaryNo
3Health Security, Pandemic Preparedness & Response (IHR, EID)
CodeBPADAIAHPrimaryNo
NAICS code2 codes
  • Testing Laboratories and Services541380
  • Other Scientific and Technical Consulting Services54169
SIC code2 codes
  • Services-Commercial Physical & Biological Research8731
  • Services-Testing Laboratories8734
Product category
Public Health Research
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Research Grants and Funding
TypeSubscription Recurring
Description

ISGlobal receives funding from governmental and international organizations including the European Commission, Spanish Ministry of Science, CERCA network, and the Severo Ochoa accreditation program. The institute also receives support from foundations such as 'la Caixa' Foundation.

isglobal.org
2Donations
TypeAffiliate Referral
Description

The institute accepts donations through its website (make a donation option available), providing individual supporters an opportunity to contribute to global health research.

isglobal.org
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components3 values
Personnel, Technology or R&D, Operations
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

The Barcelona Institute for Global Health (ISGlobal) is a non-profit research institution that conducts scientific research on global health challenges, delivers postgraduate and continuing education programmes, and translates research findings into public health policy and practice. It operates multiple research hubs and programs covering infectious diseases, environmental health, climate and health, child and maternal health, and urban health.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Night shift workers face 88% higher risk of long COVID; chronic insomnia increases risk by 42%; those with both have 2.7 times higher odds
+3 more records
Product overview1 text field

ISGlobal (Barcelona Institute for Global Health) is a research institution focused on improving global health and promoting health equity through scientific excellence. The organization operates five core research programs (Climate/Air Pollution/Urban Health, Environment/Health over Lifecourse, Global Viral/Bacterial Infections, Malaria/Neglected Diseases, Maternal/Child Health), supported by six thematic research hubs and three core scientific service facilities. ISGlobal offers educational programs including PhD, Master's (own and tropEd), and diploma programs in global health. The institute provides public-facing tools including the Forecaster.health platform for heat-related mortality risk prediction, the Heat Index Calculator for heat stress assessment, and the Healthy Urban Design Index (HUDI) for evaluating European cities on health indicators.

Product and service1 record
1Forecaster.health
Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership24 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-02-03
Description

GHIT Fund announced approximately USD 8.8 million investment in R&D projects including ISGlobal as a partner for malaria, tuberculosis, and neglected tropical diseases research. Projects span 13 countries.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Major institutional supporter of ISGlobal. The 'la Caixa' Foundation supports the Healthy Urban Design Index (HUDI) project and provides ongoing institutional backing for research activities. la Caixa logo appears as a founding partner on the website.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partner university providing academic affiliation and research collaboration. Listed as a partner institution with logo displayed on ISGlobal website.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partner university providing academic affiliation and research collaboration. Listed as a partner institution with logo displayed on ISGlobal website.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Academic hospital partner providing clinical research infrastructure and research collaboration. Listed as a partner institution.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Health park partner providing research infrastructure and clinical collaboration. Listed as a partner institution.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Regional government of Catalonia providing institutional support and funding. Listed as a partner institution.

8Gobierno de España (Government of Spain)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

National government providing institutional support through various ministries. Listed as a partner institution.

isglobal.org
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Barcelona city government providing local institutional support. Listed as a partner institution.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

ISGlobal holds official WHO Collaborating Centre status, formalizing collaboration with the World Health Organization on global health priorities.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

ISGlobal research referenced OECD preliminary data on record 23% decline in global Official Development Assistance from 2024 to 2025.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaborated with ISGlobal on DNA methylation study published in Clinical Epigenetics analyzing blood samples from 3,421 children.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaborated with ISGlobal on DNA methylation study published in Clinical Epigenetics as part of the Pregnancy and Childhood Epigenetics (PACE) Consortium.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaborated with ISGlobal on Mediterranean diet study published in BMJ Open, analyzing 3,296 participants from the English Longitudinal Study of Ageing.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

EU-funded research project spanning 25 institutions across 10 European countries plus US, Japan, and South Korea, studying health impacts of 5G exposure. ISGlobal participates in this comprehensive study through June 2027.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Led development of mRNA vivax malaria vaccine as part of GHIT Fund investment, with ISGlobal as a project partner.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partner in mRNA vivax malaria vaccine development led by Mahidol University, part of GHIT Fund portfolio.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partner in mRNA vivax malaria vaccine development led by Mahidol University, part of GHIT Fund investment.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partner in Chagas disease drug development as part of GHIT Fund's six R&D projects targeting neglected tropical diseases.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Catalan research institution network (Centres de Recerca de Catalunya) of which ISGlobal is a member. One of 11 CERCA centers to receive HR Excellence in Research badge.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Developing AI models to predict injuries in elite women's football in collaboration with ISGlobal, University of Bonn, and Made of Genes.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partner with ISGlobal and Barça Innovation Hub on AI models for predicting injuries in elite women's football.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partner with ISGlobal and Barça Innovation Hub on AI models for predicting injuries in elite women's football.

24Centre de Recerca en Salut de Manhiça (CISM, Mozambique)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

ISGlobal collaborates with CISM in Mozambique which celebrated 30 years of health research serving Africa in 2026.

isglobal.org
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
1Swiss Tropical and Public Health Institute (Swiss TPH)
TypeDirect peer
Description

Swiss-based institute combining tropical medicine, epidemiology, and global-health research with graduate education. Highly comparable to ISGlobal in malaria/NTD research portfolio, exposome and environment-health work, and WHO-adjacent role.

TypeRegional player
Description

Adjacent biomedical-research cluster in Barcelona co-located with ISGlobal's Campus Mar office. Comparable as a Barcelona-based life-sciences research ecosystem, but functions as an infrastructure host rather than a competing research institute.

TypeBroad incumbent
Description

Long-established French research foundation focused on infectious diseases, microbiology, and public health. Comparable in foundational mission, NTD and infectious-disease research, and education/training role; far larger in scale and historical scope.

TypeDirect peer
Description

Belgian institute focused on tropical and travel medicine, public health, and clinical sciences. Comparable to ISGlobal in NTD and infectious disease research, postgraduate training, and European grant-funded international research footprint.

TypeDirect peer
Description

A leading global public-health and tropical-medicine research and teaching institution. Closely comparable to ISGlobal in mission (research + postgraduate training), funding mix (grants + philanthropy), and international partnerships across infectious disease, NTDs, and climate-health.

TypeOthers
Description

Historical predecessor organization whose research mission was absorbed into ISGlobal. Listed because ISGlobal itself emerged from CREAL, sharing heritage and some ongoing faculty ties, though it is not a separate operating peer today.

TypeBroad incumbent
Description

Swedish medical university with strong epidemiology and global-health research. Comparable in research training and biomedical/public-health focus, but operates as a much broader medical university rather than a dedicated global-health institute.

TypeBroad incumbent
Description

Larger, more established global public-health school with overlapping research in epidemiology, infectious disease, and environmental health. Comparable in scope but operates at much larger scale with broader portfolio.

TypeBroad incumbent
Description

Broad, top-tier US public-health school with research programs in epidemiology, environmental health, and global health. Comparable thematic focus, but with a far larger endowment and broader mandate than ISGlobal.

TypeDirect peer
Description

Thai institution specializing in tropical medicine and global health, partnering with ISGlobal on the GHIT-funded mRNA vivax malaria vaccine. Comparable in NTD/vaccine research focus and postgraduate training programs.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI capability2 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance5 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Barcelona Institute for Global Health

Public Health Researchisglobal.org

Barcelona Institute for Global Health firmographics

Firmographics
Name
Barcelona Institute for Global Health
Legal name
Fundación Privada Instituto de Salud Global Barcelona (ISGlobal)
Website
https://isglobal.org
Company type
Private
Founded year
2018
Operating status
Operating
Headcount range
501–1,000 employees
Ownership category
akta.pro rank

Barcelona Institute for Global Health industry classification

Industry
Product category
Public Health Research
NAICS
Testing Laboratories and Services (541380), Other Scientific and Technical Consulting Services (54169)
SIC
Services-Commercial Physical & Biological Research (8731), Services-Testing Laboratories (8734)
akta.pro primary industry
Global Health Research, Evidence & Technical Assistance Organizations (HLAJAKAN)
akta.pro secondary industries
Global Health Institutes & Programs (EDAHAGAM), Health Security, Pandemic Preparedness & Response (IHR, EID) (BPADAIAH)

Keywords

  • Global health research
  • Epidemiological studies
  • Public health policy
  • Infectious disease research
  • Environmental health science

Where Barcelona Institute for Global Health is headquartered

Location

Headquarters

HQ city
Barcelona
HQ country
Spain
HQ region
Europe

Offices3 records

Markets served

Barcelona Institute for Global Health business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations

Revenue model

  1. Research Grants and Funding: ISGlobal receives funding from governmental and international organizations including the European Commission, Spanish Ministry of Science, CERCA network, and the Severo Ochoa accreditation program. The institute also receives support from foundations such as 'la Caixa' Foundation.
  2. Donations: The institute accepts donations through its website (make a donation option available), providing individual supporters an opportunity to contribute to global health research.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels7 records

Barcelona Institute for Global Health product offering

Product offering

Core offering

The Barcelona Institute for Global Health (ISGlobal) is a non-profit research institution that conducts scientific research on global health challenges, delivers postgraduate and continuing education programmes, and translates research findings into public health policy and practice. It operates multiple research hubs and programs covering infectious diseases, environmental health, climate and health, child and maternal health, and urban health.

Product overview

ISGlobal (Barcelona Institute for Global Health) is a research institution focused on improving global health and promoting health equity through scientific excellence. The organization operates five core research programs (Climate/Air Pollution/Urban Health, Environment/Health over Lifecourse, Global Viral/Bacterial Infections, Malaria/Neglected Diseases, Maternal/Child Health), supported by six thematic research hubs and three core scientific service facilities. ISGlobal offers educational programs including PhD, Master's (own and tropEd), and diploma programs in global health. The institute provides public-facing tools including the Forecaster.health platform for heat-related mortality risk prediction, the Heat Index Calculator for heat stress assessment, and the Healthy Urban Design Index (HUDI) for evaluating European cities on health indicators.

Differentiator

Problem solved

Functional benefit

Products and services

  • Forecaster.health

Quantifiable outcome

  • Night shift workers face 88% higher risk of long COVID; chronic insomnia increases risk by 42%; those with both have 2.7 times higher odds
  • +3 more outcomes

Companies that use Barcelona Institute for Global Health

Customer profile

Segments3 records

Ideal customer profiles2 records

Barcelona Institute for Global Health technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature4 records

Barcelona Institute for Global Health partnerships and signals

Strategic signal

Partnerships

24 partnerships are on record, tiered core and minor.

  • GHIT Fund (Global Health Innovative Technology Fund)coreStrategic or Co-development Partner · 3 February 2026GHIT Fund announced approximately USD 8.8 million investment in R&D projects including ISGlobal as a partner for malaria, tuberculosis, and neglected tropical diseases research. Projects span 13 countries.
  • Fundación 'la Caixa' (la Caixa Foundation)coreStrategic or Co-development PartnerMajor institutional supporter of ISGlobal. The 'la Caixa' Foundation supports the Healthy Urban Design Index (HUDI) project and provides ongoing institutional backing for research activities. la Caixa logo appears as a founding partner on the website.
  • Universitat de Barcelona (UB)coreStrategic or Co-development PartnerPartner university providing academic affiliation and research collaboration. Listed as a partner institution with logo displayed on ISGlobal website.
  • Universitat Pompeu Fabra (UPF)coreStrategic or Co-development PartnerPartner university providing academic affiliation and research collaboration. Listed as a partner institution with logo displayed on ISGlobal website.
  • Clínic Barcelona, Hospital UniversitaricoreStrategic or Co-development PartnerAcademic hospital partner providing clinical research infrastructure and research collaboration. Listed as a partner institution.
  • Parc de Salut MarcoreStrategic or Co-development PartnerHealth park partner providing research infrastructure and clinical collaboration. Listed as a partner institution.
  • Generalitat de CatalunyacoreStrategic or Co-development PartnerRegional government of Catalonia providing institutional support and funding. Listed as a partner institution.
  • Gobierno de España (Government of Spain)coreStrategic or Co-development PartnerNational government providing institutional support through various ministries. Listed as a partner institution.
  • Ajuntament de Barcelona (Barcelona City Council)coreStrategic or Co-development PartnerBarcelona city government providing local institutional support. Listed as a partner institution.
  • World Health Organization (WHO) - WHO Collaborating CentrecoreStrategic or Co-development PartnerISGlobal holds official WHO Collaborating Centre status, formalizing collaboration with the World Health Organization on global health priorities.
  • OECD (Organisation for Economic Co-operation and Development)minorStrategic or Co-development PartnerISGlobal research referenced OECD preliminary data on record 23% decline in global Official Development Assistance from 2024 to 2025.
  • University of Exeter (UK)coreStrategic or Co-development PartnerCollaborated with ISGlobal on DNA methylation study published in Clinical Epigenetics analyzing blood samples from 3,421 children.
  • University of Bristol (UK)coreStrategic or Co-development PartnerCollaborated with ISGlobal on DNA methylation study published in Clinical Epigenetics as part of the Pregnancy and Childhood Epigenetics (PACE) Consortium.
  • University College London (UCL)coreStrategic or Co-development PartnerCollaborated with ISGlobal on Mediterranean diet study published in BMJ Open, analyzing 3,296 participants from the English Longitudinal Study of Ageing.
  • GOLIAT Project Consortium (EU-funded)coreStrategic or Co-development PartnerEU-funded research project spanning 25 institutions across 10 European countries plus US, Japan, and South Korea, studying health impacts of 5G exposure. ISGlobal participates in this comprehensive study through June 2027.
  • Mahidol University (Thailand)coreStrategic or Co-development PartnerLed development of mRNA vivax malaria vaccine as part of GHIT Fund investment, with ISGlobal as a project partner.
  • Ehime University (Japan)coreStrategic or Co-development PartnerPartner in mRNA vivax malaria vaccine development led by Mahidol University, part of GHIT Fund portfolio.
  • Chulalongkorn University (Thailand)coreStrategic or Co-development PartnerPartner in mRNA vivax malaria vaccine development led by Mahidol University, part of GHIT Fund investment.
  • Eisai (Japanese pharmaceutical company)minorStrategic or Co-development PartnerPartner in Chagas disease drug development as part of GHIT Fund's six R&D projects targeting neglected tropical diseases.
  • Institució CERCAcoreStrategic or Co-development PartnerCatalan research institution network (Centres de Recerca de Catalunya) of which ISGlobal is a member. One of 11 CERCA centers to receive HR Excellence in Research badge.
  • Barça Innovation HubminorStrategic or Co-development PartnerDeveloping AI models to predict injuries in elite women's football in collaboration with ISGlobal, University of Bonn, and Made of Genes.
  • University of BonnminorStrategic or Co-development PartnerPartner with ISGlobal and Barça Innovation Hub on AI models for predicting injuries in elite women's football.
  • Made of GenesminorStrategic or Co-development PartnerPartner with ISGlobal and Barça Innovation Hub on AI models for predicting injuries in elite women's football.
  • Centre de Recerca en Salut de Manhiça (CISM, Mozambique)coreStrategic or Co-development PartnerISGlobal collaborates with CISM in Mozambique which celebrated 30 years of health research serving Africa in 2026.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Barcelona Institute for Global Health competitors and assessment

Company assessment

Direct peers

  • Swiss Tropical and Public Health Institute (Swiss TPH): Swiss-based institute combining tropical medicine, epidemiology, and global-health research with graduate education. Highly comparable to ISGlobal in malaria/NTD research portfolio, exposome and environment-health work, and WHO-adjacent role.
  • Institute of Tropical Medicine Antwerp: Belgian institute focused on tropical and travel medicine, public health, and clinical sciences. Comparable to ISGlobal in NTD and infectious disease research, postgraduate training, and European grant-funded international research footprint.
  • London School of Hygiene & Tropical Medicine: A leading global public-health and tropical-medicine research and teaching institution. Closely comparable to ISGlobal in mission (research + postgraduate training), funding mix (grants + philanthropy), and international partnerships across infectious disease, NTDs, and climate-health.
  • Mahidol University Tropical Medicine Faculty: Thai institution specializing in tropical medicine and global health, partnering with ISGlobal on the GHIT-funded mRNA vivax malaria vaccine. Comparable in NTD/vaccine research focus and postgraduate training programs.

Regional players

  • Barcelona Biomedical Research Park (PRBB): Adjacent biomedical-research cluster in Barcelona co-located with ISGlobal's Campus Mar office. Comparable as a Barcelona-based life-sciences research ecosystem, but functions as an infrastructure host rather than a competing research institute.

Broad incumbents

  • Institut Pasteur: Long-established French research foundation focused on infectious diseases, microbiology, and public health. Comparable in foundational mission, NTD and infectious-disease research, and education/training role; far larger in scale and historical scope.
  • Karolinska Institutet: Swedish medical university with strong epidemiology and global-health research. Comparable in research training and biomedical/public-health focus, but operates as a much broader medical university rather than a dedicated global-health institute.
  • Johns Hopkins Bloomberg School of Public Health: Larger, more established global public-health school with overlapping research in epidemiology, infectious disease, and environmental health. Comparable in scope but operates at much larger scale with broader portfolio.
  • Harvard T.H. Chan School of Public Health: Broad, top-tier US public-health school with research programs in epidemiology, environmental health, and global health. Comparable thematic focus, but with a far larger endowment and broader mandate than ISGlobal.

Others

Market position

Strengths5 records

Weaknesses4 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

Barcelona Institute for Global Health social profiles

Digital presence

Barcelona Institute for Global Health compliance and trust

Trust signal

Compliance5 records

Barcelona Institute for Global Health financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Barcelona Institute for Global Health leadership team

Management profile

Number of profiles

Profiles1 record

Barcelona Institute for Global Health funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Barcelona Institute for Global Health M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Barcelona Institute for Global Health

What does Barcelona Institute for Global Health do?

The Barcelona Institute for Global Health (ISGlobal) is a non-profit research institution that conducts scientific research on global health challenges, delivers postgraduate and continuing education programmes, and translates research findings into public health policy and practice. It operates multiple research hubs and programs covering infectious diseases, environmental health, climate and health, child and maternal health, and urban health.

Is Barcelona Institute for Global Health a public or private company?

Barcelona Institute for Global Health is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was Barcelona Institute for Global Health founded?

Barcelona Institute for Global Health was founded in 2018. It employs 501 to 1,000 people.

Where is Barcelona Institute for Global Health based?

Barcelona Institute for Global Health is headquartered in Barcelona, Spain, in the Europe region.

How does Barcelona Institute for Global Health make money?

Two revenue lines are on record. Research Grants and Funding is the primary driver. The others are donations.

Who are Barcelona Institute for Global Health's main competitors?

Direct peers on record are Swiss Tropical and Public Health Institute (Swiss TPH), Institute of Tropical Medicine Antwerp, London School of Hygiene & Tropical Medicine and Mahidol University Tropical Medicine Faculty. Barcelona Biomedical Research Park (PRBB) is listed as a regional player. Broad incumbents are Institut Pasteur, Karolinska Institutet, Johns Hopkins Bloomberg School of Public Health and Harvard T.H. Chan School of Public Health. Centre de Recerca en Salut Internacional de Barcelona (CRESIB) is listed as an others.

Does Barcelona Institute for Global Health have an API?

No public API is recorded for Barcelona Institute for Global Health.

What industry is Barcelona Institute for Global Health in?

Barcelona Institute for Global Health's product category is Public Health Research. Its primary akta.pro industry code is HLAJAKAN, Global Health Research, Evidence & Technical Assistance Organizations, with a secondary code of EDAHAGAM, Global Health Institutes & Programs. Its NAICS code is 541380 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
EleconomistaLa psicología sugiere que las personas que pasan más tiempo en contacto con la naturaleza y con los demás no solo reducen la soledad, sino que también fortalecen su bienestar emocionalA study led by ISGlobal in Barcelona found that social prescribing based on nature contact significantly reduces loneliness among adults in vulnerable urban areas. The intervention, part of the EU-funded RECETAS project, demonstrated that group activities with facilitators were particularly effective for those with higher initial levels of loneliness and poorer emotional well-being.Mirage NewsAtlantic Climate Key to Predicting North Africa LeishmaniasisA study led by the Barcelona Institute for Global Health (ISGlobal) and researchers from Pasteur Institutes in Tunisia, Morocco, and France has developed a seasonal forecasting system for cutaneous leishmaniasis outbreaks in North Africa using Atlantic climate patterns. The model integrates the North Atlantic Oscillation and Atlantic Multidecadal Variability to predict disease timing and intensity up to 12 months in advance, particularly in Tunisia and Morocco. This pioneering research demonstrates that long-lead forecasting is feasible in temperate regions, offering new opportunities for early warning systems against rainfall-modulated diseases.SciencedailyIvermectin: The mosquito-killing pill that dropped malaria by 26%The BOHEMIA trial, coordinated by the Barcelona Institute for Global Health (ISGlobal), demonstrated that monthly mass administration of ivermectin reduced malaria infections by 26% among children in Kenya when used alongside bed nets. The study, published in The New England Journal of Medicine and funded by Unitaid, highlights ivermectin's potential as a complementary vector control tool against insecticide-resistant mosquitoes. While the Kenya trial showed significant efficacy and safety, a parallel trial in Mozambique faced disruptions due to cyclone and cholera outbreaks, emphasizing the need for strong community engagement.EleconomistaTrabajar de noche ya se relacionaba con distintos problemas de salud, pero ahora un estudio apunta también al riesgo de Covid persistenteA study published in the Scandinavian Journal of Work, Environmental and Health, led by the Institut de Salut Global (ISGlobal), has found that night shift work and chronic insomnia significantly increase the risk of developing long COVID. The research followed 2,941 people from Catalonia, of whom 1,899 were infected with SARS-CoV-2 and 284 developed long COVID symptoms persisting beyond three months. Night shift workers face an 88% higher risk of long COVID compared to daytime workers, while chronic insomnia increases the risk by 42%, with those experiencing both having 2.7 times higher odds.BioengineeringNight Shift Work Associated With Increased Risk of Long COVIDA study by the Barcelona Institute for Global Health (ISGlobal) found that night-shift work and chronic insomnia increase the risk of developing long COVID. The research reveals night workers had an 88% higher risk of long COVID, particularly those with obesity, indicating potential interactions between metabolic health and circadian disruption in post-viral recovery.FcbarcelonaThe Barça Innovation Hub, ISGlobal, the University of Bonn, and Made of Genes develop a new artificial intelligence model to anticipate injuries in elite women's footballAn international research team led by the Barça Innovation Hub, ISGlobal, the University of Bonn, and Made of Genes has developed a new artificial intelligence model to predict injuries in elite women's football. Published in npj Digital Medicine, the framework utilizes survival analysis and decision theory to improve risk assessment accuracy based on four seasons of data from FC Barcelona. The study demonstrates that cumulative fatigue is the primary predictor of non-contact injuries, offering a more reliable tool for medical staff to manage player availability.Gadgets 360Early Heat Exposure Linked To Slower Thalamus Growth: StudyA study led by the Barcelona Institute for Global Health (ISGlobal) found that exposure to high temperatures during pregnancy and early infancy is associated with slower growth of the thalamus in children. The research, which analyzed data from 3,251 children in the Netherlands, also linked this reduced brain development to behavioral symptoms such as aggression and rule-breaking during adolescence.MedicalxpressMediterranean diet is associated with better psychological well-being, study suggestsA study published in BMJ Open by researchers from University College London and the Barcelona Institute for Global Health found that greater adherence to the Mediterranean diet is associated with improved psychological well-being among adults aged 50 to 90. The research, analyzing 3,296 participants from the English Longitudinal Study of Ageing, also found that individuals with higher Mediterranean diet adherence experienced less emotional decline during the COVID-19 pandemic. The study's authors note the findings are observational and call for further research into the relationship between diet and mental health.Inc.Millions of People Might Be Doing Intermittent Fasting Wrong, According to a StudyResearchers at the Barcelona Institute for Global Health tracked over 7,000 adults aged 40-65, collecting data on meal timing, weight, lifestyle habits, and diet, with follow-up measurements on more than 3,000 participants five years later.Gadgets 360DNA Changes Seen In Exclusively Breastfed Children, Study FindsA study published in Clinical Epigenetics found that children exclusively breastfed for at least three months carry distinct DNA methylation markers compared to those not breastfed. Researchers led by the Barcelona Institute for Global Health, University of Exeter, and University of Bristol analyzed blood samples from 3,421 children across multiple countries, finding higher methylation marks on genes associated with immunity and developmental processes. The researchers noted that while breastfeeding has known health benefits, the study cannot yet determine whether these epigenetic changes directly influence those outcomes.